Art

J-GLOBAL ID：201702242574960654   Reference number：17A1160655

Treatment with infliximab for pediatric Crohn’s disease: Nationwide survey of Japan

小児クローン病のインフリキシマブ治療:日本の全国調査【Powered by NICT】

Author (18)： Hosoi Kenji (Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan) ,  Ohtsuka Yoshikazu (Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan) ,  Fujii Tohru (Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan) ,  Kudo Takahiro (Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan) ,  Matsunaga Nobuaki (Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan) ,  Tomomasa Takeshi (PAL Children’s Clinic, Gunma, Japan) ,  Tajiri Hitoshi (Department of Pediatrics, Osaka General Medical Center, Osaka, Japan) ,  Kunisaki Reiko (Inflammatory Bowel Centre, Yokohama City University Medical Centre, Yokohama, Japan) ,  Ishige Takashi (Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Yamada Hiroyuki (Department of Pediatric Gastroenterology, Nutrition and Endocrinology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan) ,  Arai Katsuhiro (Division of Gastroenterology, National Center for Child Health and Development, Tokyo, Japan) ,  Yoden Atsushi (Department of Pediatrics, Osaka Medical College, Osaka, Japan) ,  Ushijima Kosuke (Department of Pediatrics, Kurume University Medical Center, Kurume, Japan) ,  Aomatsu Tomoki (Department of Pediatrics, Osaka Medical College, Osaka, Japan) ,  Nagata Satoru (Department of Pediatrics, Tokyo Women’s Medical University Hospital, Tokyo, Japan) ,  Uchida Keiichi (Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Mie, Japan) ,  Takeuchi Kazuo (General Health Support Center, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Shimizu Toshiaki (Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan)
Material： Journal of Gastroenterology and Hepatology
Volume： 32  Issue： 1  Page： 114-119  Publication year： 2017 
JST Material Number： W2642A  ISSN： 0815-9319  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： BACKGROUND AND AIM: Childhood-...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1160655&from=J-GLOBAL&jstjournalNo=W2642A") }}

Thesaurus term： *Japan ,  remission ,  immunotherapeutic drug ,  *child ,  safety ,  maintenance therapy ,  *Crohn disease ,  patient ,  biological preparation ,  questionnaire
Semi thesaurus term： アダリムマブ ,  有害事象 ,  炎症性腸疾患 ,  *インフリキシマブ , 【Automatic Indexing@JST】

Author keywords (4)： Crohn’s disease ,  infliximab ,  surgery ,  ulcerative colitis

JST classification (2)： Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D) ,  Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G)

Terms in the title (6)： 小児 ,  クローン病 ,  インフリキシマブ ,  治療 ,  日本 ,  調査